Pantoprazole Dosing for an 11-Year-Old Child
For an 11-year-old child with GERD or erosive esophagitis, the FDA-approved dose of pantoprazole is 40 mg once daily for children weighing ≥40 kg, or 20 mg once daily for children weighing 15 to <40 kg. 1
FDA-Approved Weight-Based Dosing Algorithm
The dosing is determined by the child's weight, not age alone:
This weight-tiered approach has been validated to achieve appropriate systemic exposure across pediatric patients aged 6-16 years, with >90% of children achieving pantoprazole exposures in the therapeutic range regardless of weight status. 2
Pharmacokinetic Considerations
The geometric mean AUC in children aged 6-11 years receiving 40 mg pantoprazole is approximately 39% higher than in adults, but this does not require dose adjustment as the exposure remains within safe and effective ranges. 1 The pharmacokinetic parameters (Cmax 1.8 mcg/mL, AUC 6.9 mcg•h/mL) demonstrate dose-independent kinetics similar to adult profiles. 3
Pantoprazole can be administered without regard to meals, though food may delay absorption by up to 2 hours without affecting overall bioavailability. 1
Clinical Efficacy Data
Both 20 mg and 40 mg doses have demonstrated significant symptom reduction in children aged 5-11 years with endoscopically proven GERD, with symptom improvement evident as early as week 1 of treatment. 4 The typical treatment duration is 4-8 weeks for erosive esophagitis. 1
Important Safety Considerations
- CYP2C19 genetic variation affects pantoprazole metabolism, with poor metabolizers showing 5-7 fold higher AUC values, but no dose adjustment is recommended based on metabolizer status. 1
- Long-term use beyond 8 weeks in pediatric patients has not been extensively studied in controlled trials. 1
- Common adverse effects include headache, diarrhea, and abdominal pain, occurring at rates similar to adults. 1
Clinical Pitfall to Avoid
Do not use lean body weight-based dosing (1.2 mg/kg LBW) in routine practice—while this approach has been studied in obese children 5, the FDA-approved weight-tiered dosing strategy is simpler, equally effective, and achieves appropriate drug exposure across all body habitus types. 2